1. Home
  2. LEA vs PCVX Comparison

LEA vs PCVX Comparison

Compare LEA & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lear Corporation

LEA

Lear Corporation

HOLD

Current Price

$125.24

Market Cap

7.2B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$60.07

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEA
PCVX
Founded
1917
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.0B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
LEA
PCVX
Price
$125.24
$60.07
Analyst Decision
Buy
Strong Buy
Analyst Count
14
4
Target Price
$132.21
$88.25
AVG Volume (30 Days)
718.8K
913.4K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
N/A
EPS
7.13
N/A
Revenue
$23,259,100,000.00
N/A
Revenue This Year
$2.50
N/A
Revenue Next Year
$3.12
N/A
P/E Ratio
$17.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$96.04
$29.87
52 Week High
$150.33
$65.00

Technical Indicators

Market Signals
Indicator
LEA
PCVX
Relative Strength Index (RSI) 40.59 60.21
Support Level $116.66 $52.18
Resistance Level $129.56 $62.54
Average True Range (ATR) 4.51 2.35
MACD -0.72 0.31
Stochastic Oscillator 19.10 94.61

Price Performance

Historical Comparison
LEA
PCVX

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: